The resulting IL-13Rα2-specific ε-TRuC-T cells lysed target-positive U251 glioblastoma cells at various effector-to-target ratios (Fig. 6c) and caused release of IFN-γ and IL-2 by T cells (Fig. 6d). The gene discussed is IFNG; the disease is glioblastoma.